HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Lu Selected Research

Paraffin

7/2011MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
4/2011The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.
9/2007Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
4/2005Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Lu Research Topics

Disease

115Neoplasms (Cancer)
04/2024 - 01/2004
41Lung Neoplasms (Lung Cancer)
07/2023 - 01/2004
36Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 08/2006
13Reperfusion Injury
04/2019 - 09/2005
10Inflammation (Inflammations)
01/2022 - 02/2009
10Ischemia
04/2019 - 09/2005
9Prostatic Neoplasms (Prostate Cancer)
12/2024 - 01/2005
8Breast Neoplasms (Breast Cancer)
04/2023 - 05/2006
6Pain (Aches)
01/2024 - 01/2013
6Neoplasm Metastasis (Metastasis)
10/2023 - 05/2011
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 01/2021
5Wounds and Injuries (Trauma)
03/2023 - 01/2017
5Fibrosis (Cirrhosis)
01/2023 - 09/2010
5Hypertrophy
12/2021 - 01/2012
5Carcinoma (Carcinomatosis)
01/2021 - 04/2005
5Carcinogenesis
01/2020 - 10/2006
4Hyperalgesia
01/2024 - 01/2013
4Hypoxia (Hypoxemia)
10/2023 - 07/2012
4Hypertension (High Blood Pressure)
08/2023 - 01/2021
4Cardiotoxicity
01/2023 - 01/2015
4Heart Failure
01/2023 - 01/2012
4Cataract (Cataracts)
11/2020 - 01/2018
4Acute Liver Failure (Fulminant Hepatic Failure)
12/2016 - 02/2009
3Myocardial Infarction
01/2023 - 10/2013
3Disease Progression
02/2022 - 03/2009
3Neuroinflammatory Diseases
01/2022 - 01/2019
3Tibial Fractures (Fracture, Tibial)
01/2022 - 08/2005
3Multiple Myeloma
04/2021 - 08/2013
3Infections
03/2021 - 09/2005
3Macular Degeneration (Age-Related Maculopathy)
04/2020 - 08/2012
3Insulin Resistance
01/2020 - 02/2009
3Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 10/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2019 - 01/2017
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2019 - 12/2012
3Pancreatitis
12/2018 - 07/2014
3Necrosis
01/2015 - 06/2009
3Adenocarcinoma
07/2013 - 01/2006
3Atherosclerosis
05/2013 - 01/2008
3Extranodal Extension
05/2011 - 11/2009

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2004
9Immune Checkpoint InhibitorsIBA
07/2023 - 01/2017
9TOR Serine-Threonine KinasesIBA
01/2019 - 08/2005
8SurvivinIBA
04/2011 - 01/2004
7Biomarkers (Surrogate Marker)IBA
08/2017 - 09/2007
6polysialic acidIBA
04/2024 - 01/2019
6Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
04/2024 - 01/2019
6Phosphotransferases (Kinase)IBA
10/2023 - 06/2004
6CytokinesIBA
01/2022 - 06/2009
6Cisplatin (Platino)FDA LinkGeneric
11/2019 - 03/2012
6EverolimusFDA Link
10/2018 - 08/2005
6Caspase 3 (Caspase-3)IBA
01/2017 - 05/2008
6Antisense OligonucleotidesIBA
07/2013 - 01/2004
5Messenger RNA (mRNA)IBA
01/2024 - 10/2013
5Silicon Dioxide (Silica)FDA LinkGeneric
04/2023 - 07/2015
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2015
5DNA (Deoxyribonucleic Acid)IBA
03/2021 - 11/2006
5Small Interfering RNA (siRNA)IBA
01/2019 - 10/2015
5Sirolimus (Rapamycin)FDA Link
01/2019 - 08/2005
5Hormones (Hormone)IBA
04/2015 - 09/2010
4EnzymesIBA
02/2024 - 06/2008
4Therapeutic UsesIBA
12/2023 - 04/2016
4MicroRNAs (MicroRNA)IBA
10/2023 - 07/2012
4CarbohydratesIBA
09/2023 - 01/2019
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2023 - 07/2018
4Hyaluronic Acid (Hyaluronan)IBA
01/2021 - 07/2018
4Paclitaxel (Taxol)FDA LinkGeneric
11/2019 - 03/2009
4Peptides (Polypeptides)IBA
11/2019 - 02/2010
4CreatinineIBA
04/2019 - 01/2012
4von Willebrand FactorIBA
07/2011 - 12/2006
4ParaffinIBA
07/2011 - 04/2005
3Cell Adhesion MoleculesIBA
04/2024 - 01/2019
31-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2024 - 02/2023
3IronIBA
09/2023 - 01/2019
3huoxue qianyangIBA
01/2022 - 12/2021
3Sirtuin 1IBA
01/2022 - 01/2018
3PolymersIBA
01/2021 - 05/2015
3HydrogelsIBA
07/2020 - 02/2010
3zeta-inhibitory peptideIBA
11/2019 - 09/2014
3Urea (Carbamide)FDA LinkGeneric
04/2019 - 01/2012
3Complement System Proteins (Complement)IBA
04/2019 - 09/2005
3LigandsIBA
01/2019 - 06/2004
3Pemetrexed (MTA)FDA Link
01/2019 - 12/2012
3Insulin (Novolin)FDA Link
12/2018 - 09/2010
3CateninsIBA
10/2018 - 07/2013
3Adenosine (Adenocard)FDA LinkGeneric
01/2017 - 12/2008
3Formaldehyde (Formol)FDA Link
01/2016 - 09/2014
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016 - 06/2004
3LipidsIBA
07/2015 - 09/2010
3ClusterinIBA
01/2014 - 11/2005
3paryleneIBA
01/2014 - 08/2010
3Tyrosine Kinase InhibitorsIBA
05/2013 - 12/2005

Therapy/Procedure

58Therapeutics
12/2024 - 03/2004
53Radiotherapy
10/2023 - 03/2004
11Drug Therapy (Chemotherapy)
02/2024 - 11/2005
7Immunotherapy
01/2023 - 09/2016
3Photochemotherapy (Photodynamic Therapy)
02/2024 - 01/2021
3Anesthesia
08/2023 - 01/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 04/2018
3Chemoradiotherapy
05/2015 - 05/2009
3Continuous Renal Replacement Therapy
07/2014 - 01/2014